Appointment of Director
Panacea Biotec Ltd has informed BSE that Mrs. Manjula Upadhyay, has been appointed as Non-Executive Independent Director of the Company w.e.f. March 30, 2015.30-03-2015
30-03-2015
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201124-02-2015
Financial Results & Limited Review for Dec 31, 2014 (Standalone)
Panacea Biotec Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.13-02-2015
Panacea Biotec Gets Pan American Health Organization (PAHO) order for supply of EasyFive-TT Vaccines worth USD 13.49 Million
Panacea Biotec Ltd has informed BSE that the Company has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The Company has been awarded for supply of 5.99 Million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 Million (equivalent to around Rs. 83.52 Crore) to meet the requirements of global immunization program....04-02-2015
Closure of Trading Window
Panacea Biotec Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on February 13, 2015, inter alia, to consider and approve the Unaudited Financial Results (Provisional) for the quarter ended December 31, 2014.Further, the trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from February 02, 2015 to February 14, 2015...02-02-2015
Shareholding Pattern For December 31, 2014
Panacea Biotec Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.20-01-2015
Disclosure of Voting results of EGM (Clause 35A)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results at the Extra-Ordinary General Meeting (EGM) of the Company held on December 06, 2015, under Clause 35A.08-01-2015
Outcome of EGM
Panacea Biotec Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on January 06, 2015.08-01-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199207-01-2015
Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Soshil Kumar Jain HUF has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE07-01-2015